We are deeply saddened by the tragic loss of Prof. Dr. med. Marcus Maurer, a good friend, colleague, and leading expert in mast cell biology and urticaria. His passion, expertise, and contributions to the medical community were profound, and his absence will be deeply felt. Marcus’ dedication to helping patients and motto of “never give up” will always inspire us. Our thoughts are with his family, friends, colleagues and all those who were privileged to know him.
Dr. Niels Riedemann, InflaRx Founder & CEO Prof. Dr. Jörg Köhl, University of Lübeck Prof. Dr. Marcus Maurer, Charité – Universitätsmedizin Berlin, Germany Prof. Christopher Sayed, University of North Carolina, Medical School; and Secretary of the HS Foundation Camilla Chong, InflaRx CMO Thomas Taapkan, InflaRx CFO Renfeng Guo, InflaRx Founder & CSO [available for Q&A] Jan Medina, InflaRx Head of IR
Webcast Timestamps
00:00:00 - Jan Medina - Kickoff
00:01:37 - Niels Riedemann - Company and speaker introduction with INF904 strategy summary
00:10:41 - Prof. Dr. med. Jörg Köhl - Current understanding of C5a/C5aR1 biology
00:28:27 - Prof. Dr. med. Marcus Maurer - The Role of C5aR in CSU
00:42:02 - Prof. Chris Sayed, MD - The Role of C5aR in HS
00:59:40 - Q&A #1 - Questions for KOLs
01:19:30 - Camilla Chong - INF904 clinical development next steps
01:28:28 - Thomas Taapkan - Commercial and financial considerations
01:34:43 - Niels Riedemann - Summary and conclusions
01:36:30 - Q&A #2 - Questions for InflaRx
01:51:35 - End
